Follow-The-Filings

VTGN VistaGen Therapeutics

VistaGen Therapeutics earnings company data as of 7:18 PM ET 8/21

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2027 Q1 14 Aug EPS
Rev $1.5M

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01
8-K 3.01
8-K 5.02,7.01,9.01
DEFA14A
8-K 7.01,8.01,9.01
8-K 5.02
8-K 2.02,9.01
10-K
8-K 8.01,9.01
8-K 5.02,7.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
8-K 5.02
8-K 3.01
8-K 5.02
8-K 7.01,9.01
8-K 8.01
8-K 5.02
8-K 2.02,9.01
10-Q
8-K 3.01
8-K 7.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 3 rows shown

Filed Form Detail Links
4 Period Jul 29, 2026
4 Period Jun 30, 2026 · 3 forms
4 Period May 18, 2026

7 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice